Plain-English translation of NCT07317544 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is one of the first times this treatment has been tested in people.
Australia
Phase
Safety & dosing / Early efficacy
Sponsor
Absci Pty Ltd.
Enrollment target
~227 participants
Started
December 2025
Primary completion
July 2028
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Clinical Trial Information Desk
Absci Pty Ltd.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.